James Frates

Track

Insider profile

James Frates's trades of SAGE Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
434.12
Quantity 96,092 +15.1%
Value US$1,528,414
Transaction date
Planned sale
Price
288.41
Quantity 32,427 +9.9%
Value US$846,171
Transaction date
Purchase
Price
450.18
Quantity 70,450 -5.2%
Value US$376,209
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2019-08-16 2019-08-15
PlS Planned sale
96,092 +15.1%
434.12
US$1,528,414 		96,092 +15.1% 434.12 US$1,528,414
2018-05-08 2018-05-08
PlS Planned sale
32,427 +9.9%
288.41
US$846,171 		32,427 +9.9% 288.41 US$846,171
2014-07-23 2014-07-23
B Purchase
70,450 -5.2%
450.18
US$376,209 		70,450 -5.2% 450.18 US$376,209